Company Filing History:
Years Active: 2012-2017
Title: Keun Na: Innovator in Liver Cancer Diagnostics
Introduction
Keun Na is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of liver cancer. With a total of 3 patents, his work focuses on innovative methods for diagnosing hepatocellular carcinoma (HCC).
Latest Patents
One of his latest patents is a plasma biomarker tool for the diagnosis of liver cancer, which includes liver carboxylesterase 1. This invention utilizes advanced techniques such as 2-D fluorescence differential gel electrophoresis (2-D DIGE), immunoprecipitation, and Nano-liquid chromatography mass spectrometry (Nano-LC-MS/MS) to identify a previously unknown protein in plasma. The discovery of liver carboxylesterase 1 (hCE1) in human plasma has shown that its secretion level is significantly higher in patients with HCC compared to healthy individuals, making it a valuable tool for early diagnosis.
Another notable patent involves monoclonal antibodies that specifically recognize human liver-carboxylesterase 1. This invention includes hybridoma cell lines that produce these antibodies, which can be used for the objective analysis of liver carboxylesterase 1 levels in various biological samples. This advancement allows for convenient and rapid diagnosis of liver cancer from urine or blood samples.
Career Highlights
Keun Na is affiliated with Yonsei University, where he continues to advance research in the field of liver cancer diagnostics. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
He has collaborated with notable colleagues, including Young-Ki Paik and Young Ki Paik, to further enhance the research and development of diagnostic tools for liver cancer.
Conclusion
Keun Na's contributions to liver cancer diagnostics through his innovative patents highlight the importance of early detection in improving patient outcomes. His work continues to pave the way for advancements in medical technology and diagnostics.